Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2026)
Cue Biopharma (CUE) recorded Other Non-Current Assets of $628,000 in Q2 2026, down 67.9% from $1.96 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma reported Other Non-Current Assets of $666,000, down 65.9% from FY2024.
- Annual Other Non-Current Assets has declined for three straight years, with a five-year compound annual growth rate of -23.7% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $1.96 million in FY2024 (-27.3%), $2.69 million in FY2023 (-13.7%), $3.12 million in FY2022 (+14.5%) and $2.72 million in FY2021 (+5.8%).
- The Q2 2026 figure is the lowest quarterly Other Non-Current Assets since Q4 2017.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 45.0% in Q2 2022, against a decline of 75.2% in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | 870,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 870,000.00 |
| Dec 31, 2025 | 914,000.00 |
| Sep 30, 2025 | 916,000.00 |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 3.25 Mn |
| Jun 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 3.40 Mn |
| Jun 30, 2022 | 4.08 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Sep 30, 2021 | 2.91 Mn |
| Jun 30, 2021 | 2.92 Mn |
API Access
Cue Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();